磺达肝癸钠相关性血小板减少症
Fondaparinux-associated Thrombocytopenia.
作者信息
Malik Jahanzeb, Javed Nismat, Kamin Matiullah
机构信息
Dr. Jahanzeb Malik, Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan.
Dr. Nismat Javed, Shifa College of Medicine, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
出版信息
Pak J Med Sci. 2021 Mar-Apr;37(2):598-599. doi: 10.12669/pjms.37.2.3522.
Abstract
Heparin-induced thrombocytopenia (HIT) is an immune-mediated condition causing thrombocytopenia and paradoxical thrombosis after exposure to heparin or low-molecular-weight heparin. It has been rarely reported by Fondaparinux, an artificial pentasaccharide similar to heparin. This manuscript presents a case of HIT associated with fondaparinux use.
摘要
肝素诱导的血小板减少症（HIT）是一种免疫介导的疾病，在接触肝素或低分子量肝素后可导致血小板减少和反常血栓形成。与肝素类似的人工合成五糖磺达肝癸钠引起HIT的情况鲜有报道。本文报告了1例与使用磺达肝癸钠相关的HIT病例。
相似文献
1
Fondaparinux-associated Thrombocytopenia.
Pak J Med Sci. 2021 Mar-Apr;37(2):598-599. doi: 10.12669/pjms.37.2.3522.
2
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia.
Thromb Haemost. 2016 Oct 28;116(5):813-822. doi: 10.1160/TH16-06-0435. Epub 2016 Sep 22.
3
Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing.
Pharmacotherapy. 2004 Jul;24(7 Pt 2):88S-94S. doi: 10.1592/phco.24.10.88s.36122.
4
Fondaparinux-associated heparin-induced thrombocytopenia.
Proc (Bayl Univ Med Cent). 2012 Jan;25(1):13-5. doi: 10.1080/08998280.2012.11928771.
5
Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1383-7. doi: 10.1345/aph.1G738. Epub 2006 Jun 20.
6
[Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
Medicina (B Aires). 2015;75(5):307-10.
7
Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
J Cardiothorac Vasc Anesth. 2014 Aug;28(4):1008-12. doi: 10.1053/j.jvca.2013.09.008. Epub 2014 Jan 16.
8
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
J Am Coll Cardiol. 2017 Nov 28;70(21):2636-2648. doi: 10.1016/j.jacc.2017.09.1099.
9
Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
Clin Appl Thromb Hemost. 2010 Dec;16(6):663-7. doi: 10.1177/1076029609347900. Epub 2009 Oct 13.
10
Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
Neth J Med. 2007 Mar;65(3):101-8.
引用本文的文献
1
Fondaparinux Failure in Heparin-Induced Thrombocytopenia With Acute Limb Ischemia: A Case Report and Literature Review.
Cureus. 2025 Jun 9;17(6):e85627. doi: 10.7759/cureus.85627. eCollection 2025 Jun.
2
Safety comparisons among different subcutaneous anticoagulants for venous thromboembolism using FDA adverse event reporting system.
Sci Rep. 2025 May 16;15(1):17070. doi: 10.1038/s41598-025-01527-9.
3
Evaluating the immunogenicity of heparin and heparin derivatives by measuring their binding to platelet factor 4 using biolayer interferometry.
Front Mol Biosci. 2022 Aug 26;9:966754. doi: 10.3389/fmolb.2022.966754. eCollection 2022.
本文引用的文献
1
Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia.
J Clin Med. 2020 Apr 24;9(4):1226. doi: 10.3390/jcm9041226.
2
Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management.
Cureus. 2020 Mar 24;12(3):e7385. doi: 10.7759/cureus.7385.
3
Diagnosis and management of heparin-induced thrombocytopenia.
Anaesth Crit Care Pain Med. 2020 Apr;39(2):291-310. doi: 10.1016/j.accpm.2020.03.012. Epub 2020 Apr 13.
4
The paradox of heparin induced thrombocytopenia-thrombosis, the role of fondaparinux and the need for new therapeutic strategies.
Int Angiol. 2020 Aug;39(4):350-351. doi: 10.23736/S0392-9590.20.04364-3. Epub 2020 Mar 26.
5
Perioperative Bleeding in Patients With Acute Coronary Syndrome Treated With Fondaparinux Versus Low-Molecular-Weight Heparin Before Coronary Artery Bypass Grafting.
Am J Cardiol. 2019 Feb 15;123(4):565-570. doi: 10.1016/j.amjcard.2018.11.028. Epub 2018 Nov 24.
6
HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux-induced HIT.
Thromb Haemost. 2014 Dec;112(6):1319-22. doi: 10.1160/TH14-08-0711. Epub 2014 Oct 16.
7
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.
Thromb Res. 2014 Jul;134(1):29-35. doi: 10.1016/j.thromres.2014.03.029. Epub 2014 Mar 18.
8
Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.
Int J Clin Pharm. 2011 Dec;33(6):997-1001. doi: 10.1007/s11096-011-9573-3. Epub 2011 Oct 16.
9
Thrombocytopenia during fondaparinux prophylaxis: HIT or something different?
Intern Emerg Med. 2010 Aug;5(4):361-3. doi: 10.1007/s11739-010-0379-4. Epub 2010 May 5.
10
Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
Am J Hematol. 2008 Nov;83(11):876-8. doi: 10.1002/ajh.21273.
Zotero 插件